Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

HeartCycle

Financiado

Cerrado

Compliance and effectiveness in HF and CHD closed loop management

Each year Cardiovascular Disease (CVD) causes over 1.9 million deaths in the EU, causing direct health costs of €105 billion. Coronary Heart Disease (CHD), half of all CVD deaths, is the single most cause of death in Europe. Heart... ver más

31/08/2013

PHILIPS ELECTRONIC...

22M€

Presupuesto del proyecto: 22M€

Líder del proyecto

PHILIPS ELECTRONICS NEDERLAND BV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 22 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-08-31 No tenemos la información de la convocatoria

0% 64% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

22 Participantes

PHILIPS ELECTRONICS NEDERLAN...

0.00€ | Lider

UPM

N.D. | Participante

VTT

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

PHILIPS ELECTRONICS NEDERLAND BV No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 22M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Each year Cardiovascular Disease (CVD) causes over 1.9 million deaths in the EU, causing direct health costs of €105 billion. Coronary Heart Disease (CHD), half of all CVD deaths, is the single most cause of death in Europe. Heart Failure (HF) – a CHD being the most frequent cause of hospitalization for people over 65 – has 10 million patients in the EU. Current treatment of HF entails recommendations from clinicians on medication, diet and lifestyle. Patients only receive feedback at doctors visits, or when facing symptoms. Daily monitoring, close follow up, and help on treatment routine is lacking. Non-adherence to the treatment regime is a major cause of suboptimal clinical benefit.HeartCycle will provide a closed-loop disease management solution to serve both HF and CHD patients, including hypertension, diabetes and arrhythmias as possible co-morbidities. This will be achieved by multi-parametric monitoring of vital signs, analysing the data and providing automated decision support, to derive therapy recommendations.The system will contain a patient loop interacting directly with the patient to support the daily treatment. It will show the health development, including treatment adherence and effectiveness. Being motivated, compliance will increase, and health will improve. The system will also contain a professional loop involving medical professionals, e.g. alerting to revisit the care plan. The patient loop is connected with hospital information systems, to ensure optimal and personalised care.Europe's health system is undergoing radical changes due to an aging population. It's moving from reactive towards preventative care, and from hospital care to care at home. Tomorrow's patients will become more empowered to take their health into their own hands. New ICT is required to enable this paradigm shift.HeartCycle, coordinated by Philips – leading in electronics and health care –, includes experts on textiles, ICT, decision support and user interaction.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores